Elucidating the specific pharmacological system of action (MOA) of Normally developing compounds could be complicated. Although Tarselli et al. (60) created the initial de novo artificial pathway to conolidine and showcased that this By natural means developing compound successfully suppresses responses to equally chemically induced and inflammatio